Inventor
Glenn Pierce
Inventor
Rancho Santa Fe, CA, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
C07KPeptides20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C12NMicroorganisms or enzymes15%
C12YEnzymes9%
Y02ATechnologies for adaptation to climate change6%
A61LMethods or apparatus for sterilising materials or objects in general3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
10,898,554Factor IX polypeptides and methods of use thereof202110,881,742Factor VIII chimeric and hybrid polypeptides, and methods of use thereof202110,656,167Assays to monitor bleeding disorders202010,568,943Factor IX polypeptides and methods of use thereof202010,561,714Factor IX polypeptides and methods of use thereof202010,548,954Factor IX polypeptides and methods of use thereof202010,221,455Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy201910,035,840Targeted coagulation factors and method of using the same201810,010,622Factor VIII chimeric and hybrid polypeptides, and methods of use thereof20189,867,873'Factor IX polypeptides and methods of use thereof'20189,675,676'Factor IX polypeptides and methods of use thereof'20179,670,475'Factor IX polypeptides and methods of use thereof'20179,629,903'Factor IX polypeptides and methods of use thereof'20179,623,091'Factor IX polypeptides and methods of use thereof'20179,422,362'Targeted coagulation factors and method of using the same'20169,241,978'Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof'20169,233,145'Factor IX polypeptides and methods of use thereof'20169,050,318'Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof'20157,534,774'Traversal of nucleic acid molecules through a fluid space and expression in repair cells'20096,689,351'Use of GM-CSF to promote accelerated wound healing'20046,613,563'Viral vectors with modified tropism'20035,965,530'Therapeutic uses of keratinocyte growth factor'19995,858,977'Method of treating diabetes mellitus using KGF'19995,824,643'Therapeutic uses of keratinocyte growth factor'19985,814,605'Therapeutic uses of keratinocyte growth factor'19985,418,222'Multi-layered collagen film compositions for delivery of proteins and methods of using same'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2004Patents assigned to AMGEN INC (6)· patent assignee history
1995–2004Based in Thousand Oaks, CA, US· patent location history
1998–2021Based in Rancho Santa Fe, CA, US· patent location history
2015–2020Patents assigned to JIANG HAIYAN (4)· patent assignee history
2015–2020Patents assigned to PIERCE GLENN (4)· patent assignee history
2015–2020Patents assigned to SOMMER JURG (3)· patent assignee history
2016–2021Based in Cambridge, MA, US· patent location history
2017–2021Patents assigned to BIOVERATIV THERAPEUTICS INC (13)· patent assignee history
2018Based in La Jolla, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOVERATIV THERAPEUTICS INC | 13 | 2017–2021 |
| AMGEN INC | 6 | 1995–2004 |
| JIANG HAIYAN | 4 | 2015–2020 |
| PIERCE GLENNself | 4 | 2015–2020 |
| SOMMER JURG | 3 | 2015–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Rancho Santa Fe, California, US | 12 | 1998–2021 |
| Cambridge, Massachusetts, US | 11 | 2016–2021 |
| Thousand Oaks, California, US | 2 | 1995–2004 |
| La Jolla, California, US | 1 | 2018 |